Literature DB >> 17525037

Molecular determinants of invasion in endometrial cancer.

M Abal1, M Llauradó, A Doll, M Monge, E Colas, M González, M Rigau, H Alazzouzi, S Demajo, J Castellví, A García, S Ramón y Cajal, J Xercavins, M H Vázquez-Levin, F Alameda, A Gil-Moreno, J Reventos.   

Abstract

Endometrial carcinoma is the most common gynaecological malignancy in the western world and the most frequent among infiltrating tumours of the female genital tract. Despite the characterisation of molecular events associated with the development of endometrial carcinoma, those associated with the early steps of infiltration and invasion in endometrial cancer are less known. Deep myometrial invasion correlates with more undifferentiated tumours, lymph-vascular invasion, node affectation and decreased global survival. In this review we present an overview of the molecular pathology of myometrial infiltration that defines the initial steps of invasion in endometrial cancer. Down-regulation of E-cadherin as a main player of epithelial to mesenchymal transition, as well as modifications on other molecules involved in cell-cell contacts, render cells with a migratory phenotype. In addition, altered signalling pathways and transcription factors associate with myometrial invasion, histologic grade and metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525037     DOI: 10.1007/s12094-007-0054-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  55 in total

1.  E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.

Authors:  Kevin Holcomb; Roberto Delatorre; Bader Pedemonte; Carla McLeod; Lisa Anderson; Joseph Chambers
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.

Authors:  Junko Sakaguchi; Satoru Kyo; Taro Kanaya; Yoshiko Maida; Manabu Hashimoto; Mitsuhiro Nakamura; Kiyofumi Yamada; Masaki Inoue
Journal:  Gynecol Oncol       Date:  2005-09       Impact factor: 5.482

3.  Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.

Authors:  J Palacios; L Catasús; G Moreno-Bueno; X Matias-Guiu; J Prat; C Gamallo
Journal:  Virchows Arch       Date:  2001-05       Impact factor: 4.064

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Nuclear localization of beta-catenin in normal and carcinogenic endometrium.

Authors:  H Nei; T Saito; H Yamasaki; H Mizumoto; E Ito; R Kudo
Journal:  Mol Carcinog       Date:  1999-07       Impact factor: 4.784

6.  Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.

Authors:  Donghai Dai; Douglas M Wolf; Elizabeth S Litman; Michael J White; Kimberly K Leslie
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

7.  Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells.

Authors:  Makoto Nishimura; Tsuyoshi Saito; Hiroshi Yamasaki; Ryuichi Kudo
Journal:  Carcinogenesis       Date:  2003-08-01       Impact factor: 4.944

8.  Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

Authors:  Gema Moreno-Bueno; David Hardisson; David Sarrió; Carolina Sánchez; Raúl Cassia; Jaime Prat; James G Herman; Manel Esteller; Xavier Matías-Guiu; José Palacios
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

9.  Mutations of the beta-catenin gene in endometrial carcinomas.

Authors:  K Kobayashi; S Sagae; Y Nishioka; T Tokino; R Kudo
Journal:  Jpn J Cancer Res       Date:  1999-01

10.  Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides.

Authors:  V Noë; J Willems; J Vandekerckhove; F V Roy; E Bruyneel; M Mareel
Journal:  J Cell Sci       Date:  1999-01       Impact factor: 5.285

View more
  16 in total

1.  ERM/ETV5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.

Authors:  Vanessa Paiva Leite de Sousa; Claudia Bessa Pereira Chaves; Janina Ferreira Loureiro Huguenin; Fábio Carvalho de Barros Moreira; Bruno Souza Bianchi de Reis; Leila Chimelli; Anke Bergmann; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

2.  IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.

Authors:  Chunfang Wang; Ke Su; Yanyan Zhang; Weiwei Zhang; Qian Zhao; Danxia Chu; Ruixia Guo
Journal:  Cancer Biol Ther       Date:  2018-11-14       Impact factor: 4.742

3.  Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

Authors:  Nadim Bou Zgheib; Douglas C Marchion; Stephen H Bush; Patricia L Judson; Robert M Wenham; Sachin M Apte; Johnathan M Lancaster; Jesus Gonzalez-Bosquet
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

4.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

5.  SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis.

Authors:  Guang-Dong Yang; Xiao-Mei Yang; Huan Lu; Yuan Ren; Ming-Ze Ma; Lin-Yan Zhu; Jing-Hao Wang; Wei-Wei Song; Wen-Ming Zhang; Rong Zhang; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

6.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 7.  The EMT signaling pathways in endometrial carcinoma.

Authors:  Eva Colas; Nuria Pedrola; Laura Devis; Tugçe Ertekin; Irene Campoy; Elena Martínez; Marta Llauradó; Marina Rigau; Mireia Olivan; Marta Garcia; Silvia Cabrera; Antonio Gil-Moreno; Jordi Xercavins; Josep Castellvi; Angel Garcia; Santiago Ramon y Cajal; Gema Moreno-Bueno; Xavier Dolcet; Francesc Alameda; Jose Palacios; Jaime Prat; Andreas Doll; Xavier Matias-Guiu; Miguel Abal; Jaume Reventos
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

8.  Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

Authors:  Sabina Sanegre; Núria Eritja; Carlos de Andrea; Juan Diaz-Martin; Ángel Diaz-Lagares; María Amalia Jácome; Carmen Salguero-Aranda; David García Ros; Ben Davidson; Rafel Lopez; Ignacio Melero; Samuel Navarro; Santiago Ramon Y Cajal; Enrique de Alava; Xavier Matias-Guiu; Rosa Noguera
Journal:  Front Cell Dev Biol       Date:  2021-06-03

9.  AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.

Authors:  Yiran Li; Yuanhui Jia; Qi Che; Qian Zhou; Kai Wang; Xiao-Ping Wan
Journal:  Oncotarget       Date:  2015-09-22

10.  A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.

Authors:  Wei Bao; Hui-Hui Wang; Fu-Ju Tian; Xiao-Ying He; Mei-Ting Qiu; Jing-Yun Wang; Hui-Juan Zhang; Li-Hua Wang; Xiao-Ping Wan
Journal:  Mol Cancer       Date:  2013-12-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.